Description
CK-MB/cTnI/Myo Fast Test Kit (Immunofluorescence Assay)
Introducing the CK-MB/cTnI/Myo Fast Test Kit, a rapid and quantitative diagnostic tool designed for in vitro determination of CK-MB, cardiac troponin I (cTnI), and myoglobin (Myo) levels in serum, plasma, or whole blood. This advanced immunofluorescence assay aids in the clinical diagnosis and prognosis of various myocardial injuries including Acute Myocardial Infarction (AMI), Unstable Angina, Acute Myocarditis, and Acute Coronary Syndrome (ACS).
Comprehensive Cardiac Marker Panel
The kit combines three critical biomarkers—CK-MB, cTnI, and Myo—to provide a comprehensive overview of cardiac health and early detection of myocardial damage.
Fast and Accurate Results
Results are available within 10 minutes, making this test ideal for emergency settings. With high sensitivity and specificity, it supports rapid and reliable decision-making in cardiac care.
Key Features
- Quantitative detection of CK-MB, cTnI, and Myo
- Results in just 10 minutes
- Sample type: Serum, plasma, or whole blood
- Wide detection range: CK-MB (2.5–80.0 ng/ml), cTnI (0.1–50.0 ng/ml), Myo (30–600 ng/ml)
- Stable storage at 4–30°C
- Shelf life: 24 months
Compatible Devices
- Getein 1100/1160/1180/1200/1600 Immunofluorescence Analyzers
- Getein 208 Hand-held Integrated System
Clinical Applications
- Early diagnosis of myocardial infarction
- Assessment of myocardial injury and thrombolytic treatment
- Estimation of infarction size
- Intraoperative evaluation of cardiac damage
- Risk classification in ACS
